589 related articles for article (PubMed ID: 28577070)
21. The effects of zoledronic acid in the bone and vasculature support of hematopoietic stem cell niches.
Soki FN; Li X; Berry J; Koh A; Sinder BP; Qian X; Kozloff KM; Taichman RS; McCauley LK
J Cell Biochem; 2013 Jan; 114(1):67-78. PubMed ID: 22833499
[TBL] [Abstract][Full Text] [Related]
22. Isolation and characterization of endosteal niche cell populations that regulate hematopoietic stem cells.
Nakamura Y; Arai F; Iwasaki H; Hosokawa K; Kobayashi I; Gomei Y; Matsumoto Y; Yoshihara H; Suda T
Blood; 2010 Sep; 116(9):1422-32. PubMed ID: 20472830
[TBL] [Abstract][Full Text] [Related]
23. Influencing hematopoietic differentiation of mouse embryonic stem cells using soluble heparin and heparan sulfate saccharides.
Holley RJ; Pickford CE; Rushton G; Lacaud G; Gallagher JT; Kouskoff V; Merry CL
J Biol Chem; 2011 Feb; 286(8):6241-52. PubMed ID: 21148566
[TBL] [Abstract][Full Text] [Related]
24. Heparan sulfate proteoglycan expression is induced during early erythroid differentiation of multipotent hematopoietic stem cells.
Drzeniek Z; Stöcker G; Siebertz B; Just U; Schroeder T; Ostertag W; Haubeck HD
Blood; 1999 May; 93(9):2884-97. PubMed ID: 10216083
[TBL] [Abstract][Full Text] [Related]
25. Heparan sulfate proteoglycans mediate interleukin-7-dependent B lymphopoiesis.
Borghesi LA; Yamashita Y; Kincade PW
Blood; 1999 Jan; 93(1):140-8. PubMed ID: 9864155
[TBL] [Abstract][Full Text] [Related]
26. Heparan sulfate inhibits hematopoietic stem and progenitor cell migration and engraftment in mucopolysaccharidosis I.
Watson HA; Holley RJ; Langford-Smith KJ; Wilkinson FL; van Kuppevelt TH; Wynn RF; Wraith JE; Merry CL; Bigger BW
J Biol Chem; 2014 Dec; 289(52):36194-203. PubMed ID: 25359774
[TBL] [Abstract][Full Text] [Related]
27. Imbalance between bone formation and resorption in hematopoietic stem/progenitor cells mobilization.
Li SD; Zhai QL; Qiu LG
Transplant Proc; 2011 Dec; 43(10):3920-6. PubMed ID: 22172873
[TBL] [Abstract][Full Text] [Related]
28. Heparan Sulfate and Heparan Sulfate Proteoglycans in Cancer Initiation and Progression.
Nagarajan A; Malvi P; Wajapeyee N
Front Endocrinol (Lausanne); 2018; 9():483. PubMed ID: 30197623
[TBL] [Abstract][Full Text] [Related]
29. Heparan sulfate regulates the anabolic activity of MC3T3-E1 preosteoblast cells by induction of Runx2.
Jackson RA; Murali S; van Wijnen AJ; Stein GS; Nurcombe V; Cool SM
J Cell Physiol; 2007 Jan; 210(1):38-50. PubMed ID: 17051597
[TBL] [Abstract][Full Text] [Related]
30. Interactions of signaling proteins, growth factors and other proteins with heparan sulfate: mechanisms and mysteries.
Billings PC; Pacifici M
Connect Tissue Res; 2015; 56(4):272-80. PubMed ID: 26076122
[TBL] [Abstract][Full Text] [Related]
31. IFNα-mediated remodeling of endothelial cells in the bone marrow niche.
Prendergast ÁM; Kuck A; van Essen M; Haas S; Blaszkiewicz S; Essers MA
Haematologica; 2017 Mar; 102(3):445-453. PubMed ID: 27742772
[TBL] [Abstract][Full Text] [Related]
32. Mobilization and homing of hematopoietic stem cells.
Suárez-Álvarez B; López-Vázquez A; López-Larrea C
Adv Exp Med Biol; 2012; 741():152-70. PubMed ID: 22457109
[TBL] [Abstract][Full Text] [Related]
33. Perlecan is responsible for thrombospondin 1 binding on the cell surface of cultured porcine endothelial cells.
Vischer P; Feitsma K; Schön P; Völker W
Eur J Cell Biol; 1997 Aug; 73(4):332-43. PubMed ID: 9270876
[TBL] [Abstract][Full Text] [Related]
34. Perlecan in human bone marrow: a growth-factor-presenting, but anti-adhesive, extracellular matrix component for hematopoietic cells.
Klein G; Conzelmann S; Beck S; Timpl R; Müller CA
Matrix Biol; 1995 Feb; 14(6):457-65. PubMed ID: 7795884
[TBL] [Abstract][Full Text] [Related]
35. Analyzing hematopoietic stem cell homing, lodgment, and engraftment to better understand the bone marrow niche.
Heazlewood SY; Oteiza A; Cao H; Nilsson SK
Ann N Y Acad Sci; 2014 Mar; 1310():119-28. PubMed ID: 24428368
[TBL] [Abstract][Full Text] [Related]
36. Influences of vascular niches on hematopoietic stem cell fate.
Kunisaki Y; Frenette PS
Int J Hematol; 2014 Jun; 99(6):699-705. PubMed ID: 24756874
[TBL] [Abstract][Full Text] [Related]
37. Heparan Sulfate in the Tumor Microenvironment.
Bartolini B; Caravà E; Caon I; Parnigoni A; Moretto P; Passi A; Vigetti D; Viola M; Karousou E
Adv Exp Med Biol; 2020; 1245():147-161. PubMed ID: 32266657
[TBL] [Abstract][Full Text] [Related]
38. Cytokines and growth factors cross-link heparan sulfate.
Migliorini E; Thakar D; Kühnle J; Sadir R; Dyer DP; Li Y; Sun C; Volkman BF; Handel TM; Coche-Guerente L; Fernig DG; Lortat-Jacob H; Richter RP
Open Biol; 2015 Aug; 5(8):. PubMed ID: 26269427
[TBL] [Abstract][Full Text] [Related]
39. Three-dimensional co-culture of mesenchymal stromal cells and differentiated osteoblasts on human bio-derived bone scaffolds supports active multi-lineage hematopoiesis in vitro: Functional implication of the biomimetic HSC niche.
Huang X; Zhu B; Wang X; Xiao R; Wang C
Int J Mol Med; 2016 Oct; 38(4):1141-51. PubMed ID: 27571775
[TBL] [Abstract][Full Text] [Related]
40. In vitro model for hematopoietic progenitor cell homing reveals endothelial heparan sulfate proteoglycans as direct adhesive ligands.
Netelenbos T; van den Born J; Kessler FL; Zweegman S; Huijgens PC; Drager AM
J Leukoc Biol; 2003 Dec; 74(6):1035-44. PubMed ID: 14525970
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
